NCT01247623 2014-11-05
Trial With Telomerase Peptide Vaccine In Combination With Temozolomide in Patients With Advanced Malignant Melanoma
Oslo University Hospital
Phase 1/2 Completed
Clinical Trials
3 trialsNCT01223209 2012-01-11
A Study, Combination, Immunologic Study of LTX-315 as Adjunct to GV1001 in Patients Following Curative Surgery for Carcinoma
Lytix Biopharma AS
Phase 1 Completed
NCT00444782 2008-12-18
A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma.
Pharmexa A/S
Phase 2 Completed